1. 1.63 IL-7 drives the tissue architecture of the RA synovium providing a niche for B-cells to mature. (31st January 2014) Authors: Churchman, Sarah M; El-Jawhari, Jehan; Goeb, Vincent; Vital, Ed; El-Sherbini, Yasser; Conaghan, Philip G; Emery, Paul; Ponchel, Frederique Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. Issue 1 (7th March 2023) Authors: Rodríguez-Carrio, Javier; Burska, Agata; Conaghan, P G; Dik, Willem A; Biesen, Robert; Eloranta, Maija-Leena; Cavalli, Giulio; Visser, Marianne; Boumpas, Dimitrios T; Bertsias, George; Wahren-Herlenius, Marie; Rehwinkel, Jan; Frémond, Marie-Louise; Crow, Mary K; Ronnblom, Lars; Vital, Ed; Versnel... Journal: RMD open Issue: Volume 9:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis. (23rd March 2014) Authors: Burska, Agata N.; Hunt, Laura; Boissinot, Marjorie; Strollo, Rocky; Ryan, Brent J.; Vital, Ed; Nissim, Ahuva; Winyard, Paul G.; Emery, Paul; Ponchel, Frederique Other Names: Sibilia Jean Academic Editor. Journal: Mediators of inflammation Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study. (May 2023) Authors: Rodziewicz, Mia; Dyball, Sarah; Lunt, Mark; McDonald, Stephen; Sutton, Emily; Parker, Ben; Bruce, Ian N; Abernethy, Rikki; Ahmad, Yasmeen; Akil, Mohamed; Bartram, Sarah; Batley, Mike; Bharadwaj, Anurag; Bruce, Ian; Carlucci, Francesco; Chan, Antoni; Dasgupta, Bhaskar; D'Cruz, David; De Lord, Deni... Journal: Lancet Issue: Volume 5:Number 5(2023) Page Start: e284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O24 Flare assessments in patients with active systemic lupus erythematosus (SLE) treated with anifrolumab in 2 phase 3 trials. (23rd March 2020) Authors: Furie, Richard; Morand, Eric F; Askanase, Anca; Vital, Ed; Kalyani, Rubana N; Abreu, Gabriel; Pineda, Lilia; Tummala, Raj Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P244 The use of anti-malarial therapy in UK Rheumatology practice. A UK-based pilot survey for the BILAG group. (23rd April 2022) Authors: Kaul, Arvind; Mason, Alice; Edwards, Christopher; Vital, Ed Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. Issue 1 (27th December 2012) Authors: Fabris, Martina; Quartuccio, Luca; Vital, Ed; Pontarini, Elena; Salvin, Sara; Fabro, Cinzia; Zabotti, Alen; Benucci, Maurizio; Manfredi, Mariangela; Ravagnani, Viviana; Biasi, Domenico; Atzeni, Fabiola; Sarzi‐Puttini, Piercarlo; Morassi, Pia; Fischetti, Fabio; Bazzicchi, Laura; Saracco, Marta; Pe... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 1(2013:Jan.) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. Issue 1 (27th December 2012) Authors: Fabris, Martina; Quartuccio, Luca; Vital, Ed; Pontarini, Elena; Salvin, Sara; Fabro, Cinzia; Zabotti, Alen; Benucci, Maurizio; Manfredi, Mariangela; Ravagnani, Viviana; Biasi, Domenico; Atzeni, Fabiola; Sarzi‐Puttini, Piercarlo; Morassi, Pia; Fischetti, Fabio; Bazzicchi, Laura; Saracco, Marta; Pe... Journal: Arthritis and rheumatism Issue: Volume 65:Issue 1(2013:Jan.) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. Issue 1 (2nd March 2023) Authors: Burska, Agata; Rodríguez-Carrio, Javier; Biesen, Robert; Dik, Willem A; Eloranta, Maija-Leena; Cavalli, Giulio; Visser, Marianne; Boumpas, Dimitrios T; Bertsias, George; Wahren-Herlenius, Marie; Rehwinkel, Jan; Frémond, Marie-Louise; Crow, Mary K; Ronnblom, Lars; Conaghan, PG; Versnel, Marjan; Vi... Journal: RMD open Issue: Volume 9:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ultrasound in rheumatology. (March 2018) Authors: Freeston, Jane; Vital, Ed Journal: Medicine Issue: Volume 46:Number 3(2018) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗